HIV counselor in front of magnet board

HIV Info

Of the more than one million people estimated to be living with HIV in the United States, one in five don't know they're infected. The best way to fight HIV is to know your status.


If you think you may have been infected with HIV/AIDS, we encourage you to get a free, confidential HIV test.

Have questions about HIV/AIDS? We have answers to Frequently Asked Questions.

HIV stands for the Human Immunodeficiency Virus, and is the virus that causes AIDS (Acquired Immune Deficiency Syndrome).  It is a virus that attacks the immune system. 

Over time, and without treatment, HIV gradually destroys the body's defenses against disease, leaving it vulnerable to many infections and cancers that do not normally develop.

AIDS is a late stage of HIV disease.  By the time of an AIDS diagnosis, HIV has already seriously damaged the body's immune system.  Often, a person living with AIDS will already have had life-threatening infections or cancers. 

Learn more about acquiring HIV, testing for HIV, and HIV treatment options.

Switch on your HIV Smarts with BETA

The Bulletin of Experimental Treatments for AIDS is your bright and brainy source on new developments in HIV prevention, evolving approaches to HIV treatment, and strategies for living well with the virus.

Latest BETA News

Hepatitis C Now a Theme at International AIDS Conference

Hepatitis C Now a Theme at International AIDS Conference

Given the advent of effective new treatments, hepatitis C was a major topic at the 20th International AIDS Conference held last week in Melbourne, Australia. An estimated 150 to 200 … Read More

No Link Between Efavirenz and Neurocognitive Impairment in Italian Study

No Link Between Efavirenz and Neurocognitive Impairment in Italian Study

The widely used antiretroviral drug efavirenz was not linked with neurocognitive impairment in a study reported this week at AIDS 2014. Efavirenz (Sustiva, also part of the popular Atripla combo … Read More

HIV Trends in San Francisco and London: An AIDS 2014 Q&A

HIV Trends in San Francisco and London: An AIDS 2014 Q&A

At AIDS 2014, underway this week in Melbourne, Australia, thousands of researchers, advocates, policymakers, and community members are gathered to learn the latest in HIV science and policy—and, importantly, to … Read More

Twenty-Plus Positive Years: An AIDS Survivor Dialogue in Melbourne

Twenty-Plus Positive Years: An AIDS Survivor Dialogue in Melbourne

An afternoon session, titled “Twenty Plus Positive Dialogues: People Who Have Lived with HIV for 20 Years or More,” on July 22 at the International AIDS Conference Global Village featured … Read More

AIDS 2014: Videos, Webcasts, and Tweets, Oh My!

AIDS 2014: Videos, Webcasts, and Tweets, Oh My!

AIDS 2014 is in full swing, with HIV cure prospects and breaking news on PrEP among the conference’s major developments. (Click here to see all of BETA’s AIDS 2014 coverage.) … Read More

Setbacks and Progress in the Search for an HIV Cure

Setbacks and Progress in the Search for an HIV Cure

The quest for a cure for HIV has been one of the themes at the 20th International AIDS Conference (AIDS 2014) taking place this week in Melbourne, with scientists reporting … Read More

PrEP Works Despite Missed Doses, Although Daily Use Is Advised

PrEP Works Despite Missed Doses, Although Daily Use Is Advised

No one who took Truvada PrEP at least four times per week acquired HIV in the iPrEx Open Label Extension (iPrEx OLE) demonstration project, according to data presented today at … Read More

See more articles on the BETA Blog...